US FDA puts clinical hold on Atara's trials for cancer cell therapies
21/01/2025 12:40
Jan 21 (Reuters) - Atara Biotherapeutics ATRA.O said on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on the drug developer's trials for its cancer cell therapies. (Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar) ((Kamal.Choudhury@thomsonreuters.com))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing